FindTrial
Sign In

The application of epidural injection of dexmedetomidine in patient undergoing transurethral resection of prostat(TURP)

The application of epidural injection of dexmedetomidine in patient undergoing transurethral resection of prostat(TURP)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015624
Enrollment
Unknown
Registered
2018-04-12
Start date
2018-04-30
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epidural anesthesia for patients undergoing TURP

Interventions

Group D:with ropivacaine and dexmedetomidine
Group R:with ropivacaine

Sponsors

Department of Anaesthesiology, Shengjing Hospital of China Medical university
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients undergoing selective TURP in Shengjing Hospital of China Medical university with ASA I-II.

Exclusion criteria

Exclusion criteria: 1. With contraindications to CSEA; 2. Failure of intraspinal anesthesia; 3. Unobstructed epidural tube; 4. Extradural catheterization; 5. Mental illness or nervous system disease; 6. Other factors can not be scored normally and patients who use analgesic drugs after operation.

Design outcomes

Primary

MeasureTime frame
Preoperative and postoperative cognitive function;Analgesic effect;Sedation effect;—

Secondary

MeasureTime frame
heart rate;blood pressure;degree of blood oxygen saturation;—

Countries

China

Contacts

Public ContactHongzhi Chen

Department of Anaesthesiology, Shengjing Hospital Of China Medical University

chenhz@sj-hospital.org+86 18940259975

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026